Home›Stock Screener›Amwill Health Care›Quarterly Results

Amwill Health Care Quarterly Results for Trading Insights

Latest Quarter Net Profit
₹11 Cr
QMarch 2025
Quarterly Results

In 2026, Amwill Health Care (AMWILL) reported revenue ₹8 Cr and net profit ₹2 Cr. For annual financials, live price and key ratios, visit AMWILL screener.

AMWILL Quarterly Results — Revenue, Profit & EPS Highlights

Amwill Health Care latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Compare with AMWILL fair price to assess whether the stock is under or overvalued.

  • Revenue of ₹41 Cr in March 2025 (+0.0% vs March 2025, -6.8% vs March 2024)
  • Net Profit of ₹11 Cr in March 2025 (+0.0% vs March 2025, -15.4% vs March 2024)
  • EBITDA of ₹12 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 29.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹6.63 in March 2025 (+0.0% vs March 2025)

Amwill Health Care Quarterly Results — Revenue, EBITDA, Net Profit & EPS

AMWILL quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 8 41 44 30 28 -80.5% -
Net Profit (₹ Cr) 2 11 13 3 3 - -
EBITDA (₹ Cr) 2 12 17 4 4 - -
EPS (₹) 299.20 6.63 8.01 2.00 1.65 - -
Operating Margin (%) 6.0% 29.0% 38.0% 14.0% 13.0% - -

AMWILL Share Price Trend — 1-Year Movement Across Quarterly Results

Amwill Health Care 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore AMWILL price trends to track price trends across different timeframes.

Profitability Ratios

Profit Margin 26.8%
EBITDA Margin 29.3%
Operating Margin 29.0%
ROE (Annual) 15.9%

Balance Sheet Highlights

Total Assets ₹72 Cr
Total Equity ₹69 Cr
Current Assets ₹22 Cr
Current Liabilities ₹0 Cr

Cash Flow Analysis

Operating Cash Flow ₹6 Cr
Investing Cash Flow ₹-46 Cr
Financing Cash Flow ₹41 Cr
Net Cash Flow ₹1 Cr

Revenue Trend (₹ Cr)

March 2023 30
March 2024 44
March 2025 41
2026 8

Net Profit Trend (₹ Cr)

March 2023 3
March 2024 13
March 2025 11
2026 2

Operating Margin Trend (%)

March 2023 14.0%
March 2024 38.0%
March 2025 29.0%
2026 6.0%

AMWILL vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Amwill Health Care latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹450,643.09 Cr 1878.2 14,875 3,125 +10.8% - 21.0% 144.5
Divis Laboratories
Sept 2025 		₹179,470.03 Cr 6760.5 2,860 689 +7.1% - 24.1% 260.3
Torrent Pharmaceuti…
Sept 2025 		₹149,048.00 Cr 4405.7 3,219 591 +11.3% - 18.4% 251.2
Cipla
Mar 2026 		₹116,053.85 Cr 1432.1 6,612 543 -14.3% -4.0% 8.2% 208.5
Dr Reddys Laborator…
Mar 2026 		₹108,804.06 Cr 1336.7 7,996 221 -12.5% -11.5% 2.8% 504.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores